ArticleMolecular biology reports2025
Identification of the potential pathogenicity of a VUS in the ASL gene associated with argininosuccinic aciduria in an Iranian family.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring the pathogenesis of a compound heterozygous variant in ATP7B associated with Wilson disease in an Iranian family.Molecular biology reports · 2026Article
- Exploring genotype-phenotype correlation of a novel SHOX gene splicing variant: Langer mesomelic dysplasia or idiopathic short stature.Molecular biology reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArgininosuccinic aciduria (ASA) is an autosomal recessive disorder resulting from a lack of argininosuccinate lyase (ASL). ASL facilitates the fourth phase of the urea cycle, when argininosuccinic acid breaks down to provide arginine and fumarate. ASL (NM_000048.3) is the sole gene identified with mutations linked to ASA.
methodsThis study involved a clinical and genetic assessment of an Iranian family with a newborn girl diagnosed with ASA, who died at 40 days of age. Whole Exome Sequencing (WES) was conducted on the proband’s parents to identify the genetic problem, followed by Sanger sequencing. Then, genetic testing was performed on Chorionic villus sampling (CVS) of two fetuses from this family during separate pregnancies spaced one year apart, and the detected variation was verified using Sanger sequencing in both of them. The next step involved examining the stability of the protein pre- and post-variation, alongside doing molecular docking investigations for the ASL protein.
resultsIn the WES analysis, the c.919T > C (p.Cys307Arg) variant was identified in the ASL gene, present in the parents as heterozygotes and in both fetuses as homozygotes. The stability of the protein in the variant state was observed to be diminished in comparison to the wild state. Additionally, the binding site of the 2-(N-omega)-L-arginino succinate ligand and the chemical bonds established with the normal and variant proteins were completely changed.
conclusionThis study facilitated the reclassification of this variant from VUS to likely pathogenic, considerably helping specialists in decision-making about this variety.
Indexed as
Identifiers
40879821What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.